AQST logo

AQST

Aquestive Therapeutics Inc.

$3.77
-$0.06(-1.57%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$388.92M
Volume
1.04M
52W Range
$2.12 - $5.80
Target Price
$8.42
Order:

Income Statement

MetricTrendChart
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$67.4M$52.6M$45.8M$50.8M$47.7M$50.6M$57.6M
Total Revenue
$67.4M$52.6M$45.8M$50.8M$47.7M$50.6M$57.6M
COST OF GOODS SOLD
Cost of Revenue
--$-20.4M$-13.0M$15.0M$19.4M$20.8M$17.9M
GROSS PROFIT
Gross Profit
$67.4M$32.2M$45.8M$35.8M$28.3M$29.8M$39.7M
OPERATING EXPENSES
Operating Expenses
$-116.4M$84.9M$88.7M$85.5M$70.4M$45.8M$75.9M
Research & Development
$23.1M$20.6M$19.9M$17.0M$17.5M$13.1M$20.3M
Research Expense
$23.1M$20.6M$19.9M$17.0M$17.5M$13.1M$20.3M
Selling, General & Administrative
$72.3M$64.3M$55.9M$53.5M$52.9M$31.8M$50.2M
Selling & Marketing Expenses
$72.3M$64.3M$55.9M--------
General & Administrative Expenses
$-1.4M$-1.6M$55.9M$53.5M$52.9M$31.8M$50.2M
Salaries & Wages
$-29.9M$-7.1M$-6.6M----$2.7M$7.1M
Depreciation & Amortization
$-3.2M$-2.9M$3.4M$2.9M$2.3M$1.2M$640.0K
Depreciation & Amortization
$-3.2M$-2.9M$2.0M$2.9M$2.3M$1.2M$640.0K
Amortization
$-1.7M$-2.0M$51.0K$51.0K$331.0K$2.1M$10.8M
Other Operating Expenses
$21.0M$-66.0K$-13.0M$-15.0M$1.8M$905.0K$5.5M
OPERATING INCOME
Operating income
$-48.9M$-52.7M$-42.9M$-34.7M$-42.1M$-15.1M$-30.8M
EBITDA
$-48.7M$-52.1M$-39.3M$-45.1M$-39.6M$1.2M$-32.7M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$7.7M$9.3M$13.0M$22.5M$12.4M$7.5M--
Intinc
$552.0K$636.0K$132.0K$423.0K$99.0K----
Net Non-Operating Interest Income/Expense
$-7.2M$-8.7M$-10.9M$-9.6M$12.3M$-8.9M--
Other Income/Expense
$5.3M$4.9M$447.0K$13.8M--$1.4M$-300.0K
Other Special Charges
$-5.3M$-4.9M$-165.0K$-13.8M--$-1.4M$300.0K
SPECIAL ITEMS
Restructring And Mn A Income
$-130.0K$-144.0K$-165.0K--------
Special Income Charges
$130.0K$144.0K$165.0K--------
Other Impairment Of Capital Assets
----------$216.0K--
PRE-TAX INCOME
EBIT
$-53.7M$-56.9M$-42.8M$-48.1M$-42.0M$-7.6M$-44.2M
Pre-Tax Income
$-61.4M$-66.2M$-55.8M$-70.5M$-54.4M$-7.6M$-44.2M
INCOME TAX
Tax Provision
----------$245.0K$-14.0K
NET INCOME
Net Income
$-61.4M$-66.2M$-55.8M$-70.5M$-54.4M$-7.9M$-44.1M
Net Income (Continuing Operations)
$-61.4M$-66.2M$-55.8M$-70.5M$-54.4M$-7.9M$-44.1M
Net Income (Discontinued Operations)
$-61.4M$-66.2M$-55.8M$-70.5M$-54.4M$-7.9M$-44.1M
Net Income (Common Stockholders)
$-61.4M$-66.2M$-27.9M$-70.5M$-54.4M$-7.9M$-44.1M
Normalized Income
------------$-44.2M
TOTALS
Total Expenses
$-116.4M$64.6M$64.8M$85.5M$89.7M$66.6M$93.8M
SHARE & EPS DATA
Average Shares Outstanding
$20.7M$25.4M$33.7M$38.1M$48.7M$61.3M$86.7M
Average Shares Outstanding (Diluted)
$20.7M$25.4M$33.6M$38.1M$48.7M$61.3M$86.7M
Shares Outstanding
$25.0M$33.6M$36.2M$41.5M$55.9M$73.3M$98.9M
Basic EPS
------$-1.85$-1.12$-0.13$-0.51
Basic EPS (Continuing Operations)
------$-1.85$-1.12$-0.13$-0.51
Diluted EPS
$-2.96$-2.61$-1.66$-1.85$-1.12$-0.13$-0.51
Diluted EPS (Continuing Operations)
------$-1.85$-1.12$-0.13$-0.51
OTHER METRICS
Other Gand A
$-1.4M$-1.6M$55.9M$53.5M$52.9M$31.8M$50.2M
Other Write Off
$-50.0K--$282.0K--------
Rent And Landing Fees
$-1.4M$-1.6M----------
Selling Expense
$72.3M$64.3M$55.9M--------
Restruct
$-130.0K$-144.0K$-165.0K--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2AQST$3.77-1.6%1.04M
3
4
5
6

Get Aquestive Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.